Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 18.408
AS - Asia 14.015
EU - Europa 11.939
SA - Sud America 2.806
Continente sconosciuto - Info sul continente non disponibili 1.230
AF - Africa 377
OC - Oceania 43
Totale 48.818
Nazione #
US - Stati Uniti d'America 17.804
SG - Singapore 6.869
CN - Cina 2.768
DE - Germania 2.594
IT - Italia 2.314
BR - Brasile 2.287
SE - Svezia 1.759
VN - Vietnam 1.280
FR - Francia 1.045
NL - Olanda 834
IN - India 729
IE - Irlanda 624
UA - Ucraina 538
GB - Regno Unito 522
PL - Polonia 486
ID - Indonesia 420
FI - Finlandia 378
HK - Hong Kong 373
JP - Giappone 358
BD - Bangladesh 301
RU - Federazione Russa 289
CA - Canada 263
AR - Argentina 187
MX - Messico 170
TR - Turchia 152
IQ - Iraq 144
KR - Corea 101
ZA - Sudafrica 99
ES - Italia 94
EC - Ecuador 81
AT - Austria 77
BE - Belgio 76
PK - Pakistan 62
CO - Colombia 58
SA - Arabia Saudita 56
CI - Costa d'Avorio 52
CZ - Repubblica Ceca 52
PH - Filippine 52
MA - Marocco 49
VE - Venezuela 46
CL - Cile 44
KE - Kenya 44
CH - Svizzera 42
UZ - Uzbekistan 42
IR - Iran 38
PY - Paraguay 37
JM - Giamaica 35
EG - Egitto 34
AU - Australia 29
JO - Giordania 27
LT - Lituania 26
PE - Perù 26
RO - Romania 26
HN - Honduras 25
MY - Malesia 25
HU - Ungheria 24
IL - Israele 24
UY - Uruguay 22
AE - Emirati Arabi Uniti 21
KZ - Kazakistan 21
OM - Oman 21
TN - Tunisia 19
AZ - Azerbaigian 17
AL - Albania 16
CR - Costa Rica 16
PT - Portogallo 16
TT - Trinidad e Tobago 16
DZ - Algeria 15
GR - Grecia 15
KG - Kirghizistan 14
NI - Nicaragua 14
PA - Panama 14
BZ - Belize 13
ET - Etiopia 12
NP - Nepal 12
BG - Bulgaria 11
BO - Bolivia 11
DO - Repubblica Dominicana 11
HR - Croazia 11
LB - Libano 10
NZ - Nuova Zelanda 10
SN - Senegal 10
TW - Taiwan 10
DK - Danimarca 9
EU - Europa 9
LV - Lettonia 9
MD - Moldavia 9
RS - Serbia 9
GT - Guatemala 8
AM - Armenia 7
LK - Sri Lanka 7
NG - Nigeria 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
AO - Angola 6
BH - Bahrain 6
MN - Mongolia 6
NO - Norvegia 6
PR - Porto Rico 6
LA - Repubblica Popolare Democratica del Laos 5
Totale 47.492
Città #
Singapore 3.874
Chandler 2.054
San Jose 2.040
Ashburn 1.884
Amsterdam 745
Beijing 640
Dublin 615
Rome 531
New York 484
Los Angeles 474
Warsaw 428
Ho Chi Minh City 404
San Mateo 401
Jakarta 377
Lauterbourg 364
Frankfurt am Main 345
Hong Kong 334
Hyderabad 333
Hanoi 330
Tokyo 328
Milan 315
Jacksonville 304
Wilmington 292
Hefei 282
Boston 276
Ann Arbor 258
Dallas 250
Nanjing 211
Houston 204
São Paulo 186
Princeton 185
Moscow 181
Santa Clara 181
Woodbridge 181
Helsinki 166
The Dalles 165
Fairfield 159
Marseille 159
Munich 159
Dearborn 148
Seattle 132
Buffalo 126
Cattolica 126
Boardman 125
Chicago 122
Atlanta 119
Council Bluffs 113
St Louis 106
Nürnberg 105
Redwood City 100
Tukwila 100
Lawrence 97
Orem 95
Rio de Janeiro 91
Seoul 87
Nuremberg 86
Phoenix 83
Brooklyn 80
London 78
Kent 77
Da Nang 74
Shanghai 69
Toronto 69
Brussels 68
Nanchang 66
Paris 65
Lappeenranta 61
Montreal 58
Johannesburg 57
Chennai 56
Denver 56
Haiphong 56
Bremen 55
Mexico City 55
Düsseldorf 54
Hangzhou 54
Mountain View 54
San Francisco 54
Belo Horizonte 53
Abidjan 52
Izmir 50
Kunming 49
Vienna 49
Baghdad 48
Brasília 48
Guangzhou 47
Naples 47
Norwalk 45
Cambridge 44
Washington 44
Dhaka 43
Turku 43
Zhengzhou 43
Leawood 41
Nairobi 40
Stockholm 39
Tashkent 39
Augusta 38
Manchester 38
Memphis 38
Totale 25.354
Nome #
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team 1.000
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 539
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 382
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 352
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 308
External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response 301
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 296
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 291
Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer 274
Laparoscopic vs percutaneous hysterectomy in obese patients: a prospective evaluation 262
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 233
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 232
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 229
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 222
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer 220
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 220
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 216
Psychological distress, body image, and nutritional status during hospitalization for gynecological cancer surgery: a prospective observational study 214
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 213
Development of an Enomogram to Predict the Rate of Loco-Regional Control After Radio-Chemotherapy and Interventional Radiotherapy in Cervical Cancer 203
Delaying surgery for patients with a previous SARS-CoV-2 infection 203
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 202
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 200
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 199
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 198
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups 196
Stereotactic Ablative Radiation Therapy for Oligometastatic Ovarian Cancer Lymph Node Disease: The MITO-RT3/RAD Phase II Trial 196
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 195
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 191
Urologic surgery in gynecologic oncology: a large single-institution experience 188
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 186
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 184
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 181
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 181
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 180
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 180
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 179
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 175
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 172
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 171
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 170
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 168
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 166
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 166
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 163
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 162
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 161
Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery 160
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 158
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 158
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 157
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 156
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 156
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 155
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 154
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 151
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 149
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 146
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 145
Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study 145
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 145
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 144
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma 144
The vulvar immunohistochemical panel (Vip) project: Molecular profiles of vulvar squamous cell carcinoma 144
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 142
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 142
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 141
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 141
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience 140
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 140
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 140
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 139
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 138
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 138
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 138
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 138
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 137
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 137
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 137
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 137
Droplet digital PCR for large genomic rearrangements detection: A promising strategy in tissue BRCA1 testing 137
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation 136
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 136
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 136
Surgical treatment of “large uterine masses” in pregnancy: A single-center experience 136
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 136
Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps 136
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 135
Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study 135
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 135
Targeting the hallmarks of ovarian cancer: The big picture 135
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 135
Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? 135
Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer 134
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients 132
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 132
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 131
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 131
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 131
Totale 19.332
Categoria #
all - tutte 208.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.412 0 118 31 255 103 67 97 431 123 151 447 589
2022/20235.646 747 716 452 765 384 729 274 401 689 98 244 147
2023/20243.296 118 886 103 287 102 372 225 125 74 193 351 460
2024/20257.133 157 134 528 235 516 295 292 304 1.036 944 1.496 1.196
2025/202620.594 2.673 534 1.159 2.101 3.521 2.193 3.160 1.011 1.365 1.375 796 706
2026/20272.959 936 2.023 0 0 0 0 0 0 0 0 0 0
Totale 48.818